Radioligands for the angiotensin II subtype 1 (AT1) receptor.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  2010-10-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/156802610793176729PMID 20583986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel O-[(11)C]methylated derivatives of candesartan as angiotensin II AT(1) receptor imaging ligands: radiosynthesis and ex vivo evaluation in rats.

  2009cited by this paper
• The renin–angiotensin system contributes to renal fibrosis through regulation of fibrocytes

  2008cited by this paper
• Chronic ACE inhibitor treatment increases angiotensin type 1 receptor binding in vivo in the dog kidney

  2008cited by this paper
• Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies

  2008cited by this paper
• Tritiation of several antihypertensive agents at high specific activity.

  2008cited by this paper
• Noninvasive imaging of angiotensin receptors after myocardial infarction.

  2008cited by this paper
• Positron-Emission Tomography Imaging of the Angiotensin II Subtype 1 Receptor in Swine Renal Artery Stenosis

  2008cited by this paper
• Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor

  2007cited by this paper
• PET Imaging of the AT1 receptor with [11C]KR31173.

  2006cited by this paper
• Angiotensin receptors: a new role in cancer?

  2005cited by this paper
• In vivo investigation of estrogen regulation of adrenal and renal angiotensin (AT1) receptor expression by PET.

  2004cited by this paper
• A novel radioligand for imaging the AT1 angiotensin receptor with PET.

  2004cited by this paper
• In Vitro and in Vivo Characterization of the Activity of Telmisartan: An Insurmountable Angiotensin II Receptor Antagonist

  2002cited by this paper
• Distinct binding properties of the AT(1) receptor antagonist [(3)H]candesartan to intact cells and membrane preparations.

  2002cited by this paper
• Physiological and Pathophysiological Functions of the AT2 Subtype Receptor of Angiotensin II: From Large Arteries to the Microcirculation

  2001cited by this paper
• Use of positron emission tomography to study AT1 receptor regulation in vivo.

  2001cited by this paper
• Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.

  1999cited by this paper
• Investigation of angiotensin II/AT1 receptors with carbon-11-L-159,884: a selective AT1 antagonist.

  1998cited by this paper
• In vivo labeling of angiotensin II receptors with a carbon-11-labeled selective nonpeptide antagonist.

  1996cited by this paper
• Development of [11C]L-159,884: a radiolabelled, nonpeptide angiotensin II antagonist that is useful for angiotensin II, AT1 receptor imaging.

  1996cited by this paper
• Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist.

  1995cited by this paper
• Characterization of the binding of [125I]L-735,286: a new nonpeptide angiotensin II AT1 receptor radioligand.

  1995cited by this paper
• Binding of valsartan to mammalian angiotensin AT1 receptors.

  1995cited by this paper
• Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.

  1995cited by this paper
• Receptor binding radiotracers for the angiotensin II receptor: radioiodinated [Sar1, Ile8]Angiotensin II.

  1994cited by this paper
• A highly potent, orally active imidazo[4,5-b]pyridine biphenylacylsulfonamide (MK-996; L-159,282): a new AT1-selective angiotensin II receptor antagonist.

  1994cited by this paper
• [3H]A-81988, a potent, selective, competitive antagonist radioligand for angiotensin AT1 receptors.

  1994cited by this paper
• Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.

  1994cited by this paper
• Characterization of cardiac angiotensin AT1 receptors by [3H]SR 47436.

  1993cited by this paper
• Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277

  1993cited by this paper
• Characterization of [3H]SK&F 108566 as a radioligand for angiotensin type-1 receptor.

  1993cited by this paper
• Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.

  1993cited by this paper
• Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.

  1993cited by this paper
• Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: quantitation with radioluminography

  1993cited by this paper
• Binding of [3H]angiotensin II and [3H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites.

  1993cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1‐receptor subtype

  1993cited by this paper
• Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.

  1992cited by this paper
• Characterization of the binding of [3H]L-158,809: a new potent and selective nonpeptide angiotensin II receptor (AT1) antagonist radioligand.

  1992cited by this paper
• [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor.

  1992cited by this paper
• Clinical characteristics of angiotensin-converting enzyme inhibitor-induced angioedema.

  1991cited by this paper
• Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency.

  1991cited by this paper
• Angiotensin II binding receptors in retinal and optic nerve head blood vessels. An autoradiographic approach.

  1991cited by this paper
• In vitro autoradiographic localization of binding to angiotensin receptors in the rat heart.

  1990cited by this paper
• Two angiotensin II binding sites in rat brain revealed using [125I]Sar1, Ile8-angiotensin II and selective nonpeptide antagonists.

  1990cited by this paper
• Angiotensin binding sites in rabbit anterior uvea and human ciliary epithelial cells.

  1990cited by this paper
• [3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.

  1990cited by this paper
• Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

  1990cited by this paper
• Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.

  1990cited by this paper
• Preliminary biochemical characterization of two angiotensin II receptor subtypes.

  1989cited by this paper
• Identification of angiotensin II receptor subtypes.

  1989cited by this paper
• Converting-enzyme inhibitors in the treatment of hypertension.

  1988cited by this paper
• Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography.

  1987cited by this paper
• Cough associated with captopril and enalapril.

  1987cited by this paper
• Autoradiographic localization of angiotensin receptors in the sheep brain.

  1986cited by this paper
• Localization of central angiotensin II receptors with [125I]-sar1, ile8-angiotensin II: periventricular sites of the anterior third ventricle.

  1986cited by this paper
• Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery.

  1986cited by this paper
• Angiotensin II receptor localization in the canine CNS.

  1985cited by this paper
• Autoradiographic localization of angiotensin II receptors in rat brain.

  1984cited by this paper
• The hepatic angiotensin II receptor. I. Characterization of the membrane-binding site and correlation with physiological response in hepatocytes.

  1982cited by this paper
• Angiotensin II: renal localization in glomerular mesangial cells by autoradiography.

  1975cited by this paper
• Inhibitory effects of central hypertensive activity of angiotensin I and II by 1-sar-8-ala-angiotensin II (saralasin acetate).

  1974cited by this paper
• A potent competitive antagonist of angiotensin II.

  1972cited by this paper
• Metabolic clearance rate of radioiodinated angiotensin II in normal men.

  1972cited by this paper
• A New, Long-Lasting Competitive Inhibitor of Angiotensin

  1972cited by this paper
• Role of the Pressor Action of Angiotensin IIin Experimental Hypertension

  1971cited by this paper
• Preparation and immunoreactive properties of monoiodinated angiotensin labelled at high specific activity.

  1971cited by this paper
• Preparation and properties of iodinated angiotensins.

  1970cited by this paper
• Angiotensin receptors.

  1970cited by this paper
• Metabolism and blood levels following infusion of a radioactive analog of angiotensin.

  1968cited by this paper
• Estimation of Angiotensin in Blood by the Preparation of Isotopic Derivatives

  1966cited by this paper
• Preparation, isolation and properties of [35-S] phenylthiocarbamyl angiotensin.

  1966cited by this paper
• Tritiated Angiotensin: Preparation and Purification

  1966cited by this paper
• Angiotensin labeled with I-131 and with tritium.

  1963cited by this paper
• Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity

  1962cited by this paper
• Angiotensin II: Its Metabolic Fate

  1962cited by this paper

• Radiotracers for Molecular Imaging of Angiotensin-Converting Enzyme 2

  2024cites this paper
• Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.

  2017cites this paper
• Losartán y sus derivados como radiotrazadores del receptor tipo 1 de agiotensina II

  2016cites this paper
• Molecular imaging of urogenital diseases.

  2014cites this paper
• Synthesis and Preliminary Evaluation of an F-18 Labeled Fluoropyridine Losartan Analog as a Novel PET Tracer for Imaging AT1 Receptors

  2012cites this paper